Evaluation of cfDNA as a Marker of Response in Rectal Cancer

NCT04319354 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Hospital Pedro Hispano

Collaborators